How to Choose an Eye Cancer Specialist (Ocular Oncologist)

Finding a tumor in or around your eye, or your child's, is frightening, and one of the first decisions is who should treat it. Knowing how to choose an eye cancer specialist matters because these tumors are rare and their treatment is highly specialized. In short: look for subspecialty training, experience with your tumor, the full range of imaging, a multidisciplinary team and clear communication.

What is an ocular oncologist?

An ocular oncologist is an ophthalmologist (eye doctor) with additional subspecialty training — usually a fellowship after residency — in tumors inside the eye, on its surface, in the eyelids and in the orbit (eye socket). Some also have oculoplastic training for eyelid and orbital surgery.

These tumors are uncommon. Uveal melanoma, the most frequent eye cancer in adults, affects about 5–6 people per million each year in the United States; conjunctival melanoma about 130 people a year in the whole United States; and the United Kingdom sees around 40–50 children with retinoblastoma a year. Most general eye doctors see them only occasionally.

Why does subspecialty experience matter for eye tumors?

Several eye tumors resemble harmless conditions, and the way a tumor is first handled can affect the result:

• Sebaceous carcinoma of the eyelid can masquerade as a chalazion (a common eyelid cyst) or as one-sided inflammation, delaying diagnosis; a "chalazion" that keeps returning should be biopsied (see eyelid cancer).
• Growths on the white of the eye can hide abnormal cells: in two studies, 1.7% and 9.8% of removed "pterygia" contained precancerous or cancerous changes (see conjunctival tumors).
• Some orbital tumors, such as the benign mixed tumor of the tear gland, should be removed whole rather than sampled, because cutting into them can seed recurrences (see orbital tumors).
• An eye with a suspected tumor should not be treated by evisceration (removal of the eye's contents), because tumor cells may be left behind.

Studies comparing eye tumor centers are scarce, but in other rare cancers the evidence is clearer: in a French nationwide study of 29,497 people with sarcoma, surgery at reference centers with specialist tumor boards was linked to fewer local relapses and roughly a one-third lower risk of death.

How to choose an eye cancer specialist: six things to check

1. Subspecialty training

Ask where the doctor trained in ocular oncology. A fellowship at an established ocular oncology service shows focused training in diagnosing and treating eye tumors.

2. Experience with your type of tumor

A specialist who treats many adults with melanoma may see few children with retinoblastoma, and eyelid and orbital tumors need surgical skills of their own. Ask how often the doctor treats tumors like yours, and which parts of the treatment they perform themselves.

3. The full range of imaging

Most tumors inside the eye are diagnosed from their appearance on imaging rather than by biopsy. Key tests include wide-field photography, ultrasound, optical coherence tomography (OCT), autofluorescence and angiography; anterior segment OCT or ultrasound biomicroscopy for the front of the eye; MRI or CT of the orbit; and examination under anesthesia for young children. In retinoblastoma, MRI is preferred to CT, because radiation raises the risk of later cancers in children with the hereditary form (see how eye tumors are diagnosed).

4. A multidisciplinary team

No single doctor delivers every eye cancer treatment. Care can involve radiation oncologists and physicists (plaque brachytherapy, proton or stereotactic radiotherapy), interventional radiologists (intra-arterial chemotherapy), pediatric and medical oncologists, pathologists, geneticists and ocularists, who make artificial eyes. Guidelines such as the NCCN guidelines for uveal melanoma emphasize care planned by such teams. Ask who else will be involved and how decisions are made.

5. Clear communication

After the first appointment you should know the diagnosis and how certain it is, the options — including eye-preserving ones — with their likely effect on vision, and the next steps. A written summary and copies of your images are good signs.

6. Openness to second opinions

Good specialists welcome second opinions and share images and reports. For rare cancers, an independent review is a normal step, not a sign of distrust.

What questions should you ask your ocular oncologist?

Write your questions down and bring a family member:

• What exactly is the diagnosis, and how certain is it? Would a biopsy or genetic test help?
• How large is the tumor, and what is its stage or group?
• What are all the options, including eye-preserving ones — which do you recommend, and why?
• Which parts of the treatment will you carry out, and which will other specialists deliver?
• What is the likely effect on my vision and on the appearance of the eye?
• What are the main side effects, short and long term?
• What is the chance that the tumor comes back or spreads, and how will we watch for it?
• How often will I need follow-up, and can some of it take place near home?
• For a child: is genetic testing recommended, and should brothers and sisters be examined?

Which warning signs should make you pause?

Most specialists give balanced advice. Be cautious if you encounter:

• promises of certain success — no one can promise the outcome of cancer treatment;
• a single option with no discussion of alternatives — for example, whether the eye could be kept;
• pressure to decide at once when there is no urgency — where there is, as with retinoblastoma or fast-growing tumors, a good doctor explains why;
• reluctance to share images, reports or pathology slides, or to discuss a second opinion;
• a package price offered before anyone has examined you or reviewed your scans;
• no clear plan for follow-up after treatment.

When should you get an ocular oncology second opinion?

Consider one when the diagnosis is uncertain, when removal of the eye is proposed, when doctors disagree or when a tumor returns. For slow-growing tumors the time is usually well spent; for fast-growing tumors and for children with retinoblastoma, discuss the urgency with your doctor and do not delay treatment. Many reviews can start remotely — see how an eye tumor second opinion works.

Prof. Türkoğlu's training and practice

Prof. Türkoğlu's verifiable background (see the full profile):

• Professor of Ophthalmology since 2022, a rank held at Akdeniz University Faculty of Medicine in Antalya, where she was also assistant professor (2014) and associate professor (2017); she now practices privately in Antalya;
• more than 20 years in ophthalmology, since her residency began in 2005;
• one-year ocular oncology research fellowship at the Ocular Oncology Service of Wills Eye Hospital, Philadelphia (2015–2016), working with Dr. Carol L. Shields;
• observership in ocular oncology at the National Cancer Center of Japan, Tokyo (2019);
• principal investigator of a research project on intravitreal melphalan chemotherapy for resistant or recurrent retinoblastoma (2015–2016);
• 41 papers indexed in PubMed, including research on photodynamic therapy for small choroidal melanoma (see publications).

She treats adults and children. Prof. Türkoğlu evaluates each case, explains the options and plans treatment with the patient; where a method needs specialized facilities, it is delivered together with the relevant specialist teams.